Latest Regulatory Milestones News

The ACCC has given informal clearance for the merger between Southern Cross Media Group and Seven West Media, marking a key regulatory milestone. The deal still awaits shareholder and ACMA approvals before completion.

The Australian Competition and Consumer Commission has given the green light to Southern Cross Media’s proposed acquisition of Seven West Media, marking a significant regulatory milestone in the evolving Australian media landscape.

Anteris Technologies has gained FDA approval to start patient recruitment in the US for its pivotal PARADIGM Trial, following initial European regulatory success. The company advances manufacturing and clinical readiness as it pushes toward key regulatory milestones.

Neurotech International has received a $4.73 million R&D tax incentive refund, reinforcing its clinical development efforts in paediatric neurological disorders. The funds will support ongoing trials and working capital needs.

Marimaca Copper's Chilean subsidiary has obtained formal environmental approval for its Marimaca Oxide Project, clearing a critical hurdle toward construction readiness in the second half of 2026. This milestone follows years of environmental and social groundwork and sets the stage for the next permitting phase.

MA Financial Group advances exclusive due diligence on a major Queensland retail asset and prepares a new ASX-listed credit notes offer, signaling strategic growth moves.

Memphasys Limited has successfully raised over $1.1 million through a pro-rata entitlement offer to accelerate the commercialisation of its innovative Felix™ sperm selection system, targeting key regulatory approvals and market expansion.

Mandrake Resources has signed a term sheet with DISA Technologies to explore recovering uranium and critical minerals from abandoned mine waste in Utah, leveraging a unique US regulatory license and strong government backing.

GoviEx Uranium has received the Supreme Court of British Columbia's final approval for its reverse takeover of Tombador Iron, setting the stage for completion by mid-November 2025.

AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.

Neuren Pharmaceuticals reported a milestone quarter with DAYBUE net sales reaching US$101.1 million, driving a 24% jump in royalty income. The expanding patient base and community physician uptake signal strong growth ahead.

Novo Resources reports impressive high-grade gold rock chip assays from its Tibooburra Gold Project, highlighting new targets and advancing exploration with drilling plans underway.